Metabolic targeting can improve the efficiency of brain tumor biopsies
Brain tumors comprise a heterogeneous group of diseases, featuring different biology, prognosis, and treatment. The most known forms are malignant gliomas and metastases. Brain biopsy is a recognized technique in the management of intracranial space-occupying lesions and tumors in particular. Tumor...
Gespeichert in:
| Veröffentlicht in: | Seminars in oncology 2020-04, Vol.47 (2-3), p.148-154 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 154 |
|---|---|
| container_issue | 2-3 |
| container_start_page | 148 |
| container_title | Seminars in oncology |
| container_volume | 47 |
| creator | Villena Martín, Maikal Pena Pardo, Francisco José Jiménez Aragón, Fátima Borras Moreno, José María García Vicente, Ana María |
| description | Brain tumors comprise a heterogeneous group of diseases, featuring different biology, prognosis, and treatment. The most known forms are malignant gliomas and metastases. Brain biopsy is a recognized technique in the management of intracranial space-occupying lesions and tumors in particular. Tumor heterogeneity of malignant brain lesions has been described and can lead to significant sampling errors in stereotactic biopsy. Different methods have been used to perform biopsies, including biopsy guided by CT or RMI, echoguided or stereotactic. The choice of the target with the help of PET and MRI with spectroscopy allows one to identify metabolically more active areas of the tumor, and in this way reduce the rate of negative results. |
| doi_str_mv | 10.1053/j.seminoncol.2020.04.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2411106826</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0093775420300397</els_id><sourcerecordid>2411106826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-734c7afa55850f466a1f0b175818a21e1bfbacc764401f7d576518f8eb08978c3</originalsourceid><addsrcrecordid>eNqFkLtOxDAQRS0EguXxC8glTcL4FZsSEAtIIBqoLcc7Bq-SeLGzSPw9geVRUk1z7tyZQwhlUDNQ4nRZF-zjkAafupoDhxpkDaC3yIwpwSujwWyTGcCZqLRWco_sl7IE4Exzvkv2BFdMSC5mZH6Po2tTFz0dXX7GMQ7P1LuBxn6V0xvS8QUphhB9xMG_0xRom10c6LjuU6ZtTKsSsRySneC6gkff84A8za8eL2-qu4fr28vzu8oLLcdKC-m1C04poyDIpnEsQMu0Msw4zpC1oXXe60ZKYEEvlG4UM8FgC-ZMGy8OyMlm73Tc6xrLaPtYPHadGzCti-WSMQaN4c2Emg3qcyolY7CrHHuX3y0D-2nRLu2fRftp0YK0k8Upevzdsm57XPwGf7RNwMUGwOnXt4jZli8_uIgZ_WgXKf7f8gFxoIhZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2411106826</pqid></control><display><type>article</type><title>Metabolic targeting can improve the efficiency of brain tumor biopsies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Villena Martín, Maikal ; Pena Pardo, Francisco José ; Jiménez Aragón, Fátima ; Borras Moreno, José María ; García Vicente, Ana María</creator><creatorcontrib>Villena Martín, Maikal ; Pena Pardo, Francisco José ; Jiménez Aragón, Fátima ; Borras Moreno, José María ; García Vicente, Ana María</creatorcontrib><description>Brain tumors comprise a heterogeneous group of diseases, featuring different biology, prognosis, and treatment. The most known forms are malignant gliomas and metastases. Brain biopsy is a recognized technique in the management of intracranial space-occupying lesions and tumors in particular. Tumor heterogeneity of malignant brain lesions has been described and can lead to significant sampling errors in stereotactic biopsy. Different methods have been used to perform biopsies, including biopsy guided by CT or RMI, echoguided or stereotactic. The choice of the target with the help of PET and MRI with spectroscopy allows one to identify metabolically more active areas of the tumor, and in this way reduce the rate of negative results.</description><identifier>ISSN: 0093-7754</identifier><identifier>EISSN: 1532-8708</identifier><identifier>DOI: 10.1053/j.seminoncol.2020.04.007</identifier><identifier>PMID: 32513423</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Brain Neoplasms - diagnosis ; Brain Neoplasms - surgery ; Cerebral Biopsy ; Choline PET ; Female ; Gioblastomas ; Humans ; Image-Guided Biopsy - methods ; Magnetic Resonance Imaging - methods ; Magnetic Resonance Spectroscopy - methods ; Male ; Middle Aged ; Multimodal Imaging - methods ; Neuronavigation ; Neuronavigation - methods ; Positron-Emission Tomography - methods ; Tumor heterogeneity</subject><ispartof>Seminars in oncology, 2020-04, Vol.47 (2-3), p.148-154</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-734c7afa55850f466a1f0b175818a21e1bfbacc764401f7d576518f8eb08978c3</citedby><cites>FETCH-LOGICAL-c374t-734c7afa55850f466a1f0b175818a21e1bfbacc764401f7d576518f8eb08978c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0093775420300397$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32513423$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Villena Martín, Maikal</creatorcontrib><creatorcontrib>Pena Pardo, Francisco José</creatorcontrib><creatorcontrib>Jiménez Aragón, Fátima</creatorcontrib><creatorcontrib>Borras Moreno, José María</creatorcontrib><creatorcontrib>García Vicente, Ana María</creatorcontrib><title>Metabolic targeting can improve the efficiency of brain tumor biopsies</title><title>Seminars in oncology</title><addtitle>Semin Oncol</addtitle><description>Brain tumors comprise a heterogeneous group of diseases, featuring different biology, prognosis, and treatment. The most known forms are malignant gliomas and metastases. Brain biopsy is a recognized technique in the management of intracranial space-occupying lesions and tumors in particular. Tumor heterogeneity of malignant brain lesions has been described and can lead to significant sampling errors in stereotactic biopsy. Different methods have been used to perform biopsies, including biopsy guided by CT or RMI, echoguided or stereotactic. The choice of the target with the help of PET and MRI with spectroscopy allows one to identify metabolically more active areas of the tumor, and in this way reduce the rate of negative results.</description><subject>Adult</subject><subject>Aged</subject><subject>Brain Neoplasms - diagnosis</subject><subject>Brain Neoplasms - surgery</subject><subject>Cerebral Biopsy</subject><subject>Choline PET</subject><subject>Female</subject><subject>Gioblastomas</subject><subject>Humans</subject><subject>Image-Guided Biopsy - methods</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multimodal Imaging - methods</subject><subject>Neuronavigation</subject><subject>Neuronavigation - methods</subject><subject>Positron-Emission Tomography - methods</subject><subject>Tumor heterogeneity</subject><issn>0093-7754</issn><issn>1532-8708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLtOxDAQRS0EguXxC8glTcL4FZsSEAtIIBqoLcc7Bq-SeLGzSPw9geVRUk1z7tyZQwhlUDNQ4nRZF-zjkAafupoDhxpkDaC3yIwpwSujwWyTGcCZqLRWco_sl7IE4Exzvkv2BFdMSC5mZH6Po2tTFz0dXX7GMQ7P1LuBxn6V0xvS8QUphhB9xMG_0xRom10c6LjuU6ZtTKsSsRySneC6gkff84A8za8eL2-qu4fr28vzu8oLLcdKC-m1C04poyDIpnEsQMu0Msw4zpC1oXXe60ZKYEEvlG4UM8FgC-ZMGy8OyMlm73Tc6xrLaPtYPHadGzCti-WSMQaN4c2Emg3qcyolY7CrHHuX3y0D-2nRLu2fRftp0YK0k8Upevzdsm57XPwGf7RNwMUGwOnXt4jZli8_uIgZ_WgXKf7f8gFxoIhZ</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Villena Martín, Maikal</creator><creator>Pena Pardo, Francisco José</creator><creator>Jiménez Aragón, Fátima</creator><creator>Borras Moreno, José María</creator><creator>García Vicente, Ana María</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202004</creationdate><title>Metabolic targeting can improve the efficiency of brain tumor biopsies</title><author>Villena Martín, Maikal ; Pena Pardo, Francisco José ; Jiménez Aragón, Fátima ; Borras Moreno, José María ; García Vicente, Ana María</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-734c7afa55850f466a1f0b175818a21e1bfbacc764401f7d576518f8eb08978c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Brain Neoplasms - diagnosis</topic><topic>Brain Neoplasms - surgery</topic><topic>Cerebral Biopsy</topic><topic>Choline PET</topic><topic>Female</topic><topic>Gioblastomas</topic><topic>Humans</topic><topic>Image-Guided Biopsy - methods</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multimodal Imaging - methods</topic><topic>Neuronavigation</topic><topic>Neuronavigation - methods</topic><topic>Positron-Emission Tomography - methods</topic><topic>Tumor heterogeneity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Villena Martín, Maikal</creatorcontrib><creatorcontrib>Pena Pardo, Francisco José</creatorcontrib><creatorcontrib>Jiménez Aragón, Fátima</creatorcontrib><creatorcontrib>Borras Moreno, José María</creatorcontrib><creatorcontrib>García Vicente, Ana María</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Villena Martín, Maikal</au><au>Pena Pardo, Francisco José</au><au>Jiménez Aragón, Fátima</au><au>Borras Moreno, José María</au><au>García Vicente, Ana María</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic targeting can improve the efficiency of brain tumor biopsies</atitle><jtitle>Seminars in oncology</jtitle><addtitle>Semin Oncol</addtitle><date>2020-04</date><risdate>2020</risdate><volume>47</volume><issue>2-3</issue><spage>148</spage><epage>154</epage><pages>148-154</pages><issn>0093-7754</issn><eissn>1532-8708</eissn><abstract>Brain tumors comprise a heterogeneous group of diseases, featuring different biology, prognosis, and treatment. The most known forms are malignant gliomas and metastases. Brain biopsy is a recognized technique in the management of intracranial space-occupying lesions and tumors in particular. Tumor heterogeneity of malignant brain lesions has been described and can lead to significant sampling errors in stereotactic biopsy. Different methods have been used to perform biopsies, including biopsy guided by CT or RMI, echoguided or stereotactic. The choice of the target with the help of PET and MRI with spectroscopy allows one to identify metabolically more active areas of the tumor, and in this way reduce the rate of negative results.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32513423</pmid><doi>10.1053/j.seminoncol.2020.04.007</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0093-7754 |
| ispartof | Seminars in oncology, 2020-04, Vol.47 (2-3), p.148-154 |
| issn | 0093-7754 1532-8708 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2411106826 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Brain Neoplasms - diagnosis Brain Neoplasms - surgery Cerebral Biopsy Choline PET Female Gioblastomas Humans Image-Guided Biopsy - methods Magnetic Resonance Imaging - methods Magnetic Resonance Spectroscopy - methods Male Middle Aged Multimodal Imaging - methods Neuronavigation Neuronavigation - methods Positron-Emission Tomography - methods Tumor heterogeneity |
| title | Metabolic targeting can improve the efficiency of brain tumor biopsies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T14%3A56%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20targeting%20can%20improve%20the%20efficiency%20of%20brain%20tumor%20biopsies&rft.jtitle=Seminars%20in%20oncology&rft.au=Villena%20Mart%C3%ADn,%20Maikal&rft.date=2020-04&rft.volume=47&rft.issue=2-3&rft.spage=148&rft.epage=154&rft.pages=148-154&rft.issn=0093-7754&rft.eissn=1532-8708&rft_id=info:doi/10.1053/j.seminoncol.2020.04.007&rft_dat=%3Cproquest_cross%3E2411106826%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2411106826&rft_id=info:pmid/32513423&rft_els_id=S0093775420300397&rfr_iscdi=true |